Pathway launches SensiTrop HIV tropism assay in US
This article was originally published in Clinica
SensiTrop, a new molecular heteroduplex tracking assay (HTA) designed to determine the co-receptor tropism status of HIV infected patients, has been launched in the US by Pathway Diagnostics.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.